Ask AI

Downloadable Slides

Share

Program Content

Activities

  • Treatment of HER2 Positive Advanced Bladder Cancer
    Personalizing Treatment of HER2-Positive Advanced Bladder Cancer: Expert Guidance on the Latest Evidence for HER2-Targeted ADCs
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 26, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.